Drugs

The link between dementia and neuroplasticity inspires researchers to test psychedelics as a potential treatment for cognitive impairment.

Combining AI with traditional wet lab work creates a virtuous circle from lab to data and back to the lab.

Scientists have created an organism that defies the rules of biology by using nonstandard amino acids. And you probably have some questions.

Longevity startups are riding high as a wave of gene therapies advance through clinical trials. Can they actually turn back the clock?

Depleted by metastatic breast cancer, the author undertakes a psilocybin journey.

Bit.bio’s new approach for reprogramming pluripotent stem cells could standardize the reliable, large-scale manufacture of cells for research and therapy.

Getting geroprotective drugs to market for specific disease applications is the first step in eventually making them available for healthier aging.

Oregon’s grand experiment in training psychedelic facilitators is facing a tangle of ambiguity and red tape.

How a daring team of parents and doctors forged a new path for medicine.

Fauna Bio mines squirrel genomes for clues to developing new drugs for humans.